NEW YORK (GenomeWeb) – EKF Diagnostics today announced that it has received two new proposals regarding the sale of its point-of-care (POC) diagnostics business.

EKF said in a statement that it has received a second non-binding preliminary offer of $115 million to $125 million in cash for its POC diagnostics unit from an undisclosed third party.

In a separate statement, the firm said it has received a third non-binding preliminary proposal for the POC diagnostics business from Chinese firm Jinjing Group that may or may not lead to an offer.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.